COVID-19 pandemic
Nepal grants a conditional emergency use approval for the Russian Sputnik V vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology.
Sources: The Kathmandu Post
Changes
- Nepal grants a conditional emergency use approval to Russian Sputnik V vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology.
- Nepal grants a conditional emergency use approval for the Russian Sputnik V vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology.